COVID-19 vaccine reactogenicity in persons with multiple sclerosis

被引：0
|
作者：
Briggs, F. [1 ]
Mateen, F. [2 ]
Schmidt, H. [3 ]
Currie, K. [4 ]
Siefers, H. [5 ]
Crouthamel, S. [6 ]
Bebo, B. [7 ]
Fiol, J. [8 ]
Racke, M. [9 ]
O'Connor, K. [10 ,11 ]
Kolaczkowski, L. [12 ]
Klein, P. [13 ]
McBurney, R. [3 ]
Loud, S. [3 ]
机构：
[1] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
[2] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[3] Accelerated Cure Project MS, Waltham, MA USA
[4] Currie Consultancy Agcy LLC, Eastover, SC USA
[5] Int AIDS Vaccine Initiat, Frederick, MD USA
[6] Mammoth Hosp, Mammoth Lakes, CA USA
[7] Natl Multiple Sclerosis Soc USA, Portland, OR USA
[8] Natl Multiple Sclerosis Soc USA, Bel Air, CA USA
[9] Quest Diagnost, Med Affairs, Secaucus, NJ USA
[10] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA
[11] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA
[12] iConquerMS, Beavercreek, OH USA
[13] iConquerMS, Waltham, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P944
引用
收藏
页码：768 / 769
页数：2
相关论文
共 50 条
  • [31] New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
    Toljan, K.
    Amin, M.
    Kunchok, A.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 86 - 87
  • [32] Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica
    Januel, Edouard
    De Seze, Jerome
    Vermersch, Patrick
    Maillart, Elisabeth
    Bourre, Bertrand
    Pique, Julie
    Moisset, Xavier
    Bensa, Caroline
    Maarouf, Adil
    Pelletier, Jean
    Vukusic, Sandra
    Audoin, Bertrand
    Louapre, Celine
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (07) : 1155 - 1159
  • [33] Insight in booster COVID-19 vaccine and disease modifying therapy in multiple sclerosis
    Beard, Katherine
    Sriwastava, Shitiz
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 430
  • [34] New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
    Toljan, Karlo
    Amin, Moein
    Kunchok, Amy
    Ontaneda, Daniel
    JOURNAL OF NEUROIMMUNOLOGY, 2022, 362
  • [35] Multiple sclerosis patients and COVID-19
    Mado, Hubert
    Adamczyk-Sowa, Monika
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2021, 57 (01):
  • [36] Multiple sclerosis patients and COVID-19
    Hubert Mado
    Monika Adamczyk-Sowa
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57
  • [37] Multiple sclerosis, rituximab, and COVID-19
    Langer-Gould, Annette
    Smith, Jessica B.
    Li, Bonnie H.
    Beaber, Brandon E.
    Brara, Sonu M.
    Debacker, Julie
    Nielsen, Allen Scott
    Amirova, Samira
    Ayeni, Oluwasheyi
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (04): : 938 - 943
  • [38] Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
    Thuy Trang Nguyen
    Trang Ho Thu Quach
    Thanh Mai Tran
    Huynh Ngoc Phuoc
    Ha Thi Nguyen
    Tuong Kha Vo
    Giau Van Vo
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 147
  • [39] Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry
    Stanikic, Mina
    Twomey, Eric
    Puhan, Milo A.
    Kamm, Christian P.
    Salmen, Anke
    Ajdacic-Gross, Vladeta
    Zecca, Chiara
    Gobbi, Claudio
    von Wyl, Viktor
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 74
  • [40] Exploring COVID-19 experiences for persons with multiple sclerosis and carers: An Australian qualitative study
    Correia, Helen
    Martin-Lynch, Pamela
    Finlayson, Marcia
    Learmonth, Yvonne C.
    HEALTH EXPECTATIONS, 2023, 26 (02) : 785 - 794
12345